Primary Record
actinonin
- In stock
- 3,154 g
- Purity
- 99.3 %
- CAS
- 13434-13-4
Compound Identifiers & Properties
- CAS
- 13434-13-4
- PubChem CID
- 443600
- SMILES
- CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO
- Canonical SMILES
- CCCCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)N1CCC[C@H]1CO)C(C)C
Names & Synonyms
- actinonin
- Actinonine
- (-)-actinonin
- 13434-13-4
- P18SPA8N0K
- 3g5k
- 3m6p
- 3m6q
- 3m6r
- 3pn4
- 4dr9
- 4je7
- UNII-P18SPA8N0K
- RefChem:449921
- Spectrum2_000628
- Spectrum3_000680
- Spectrum4_001932
- Spectrum5_000728
- AC1L9EW8
- DTXSID70928580
- CHEMBL308333
- C19H35N3O5
- Lopac0_000010
- BSPBio_002379
- KBioGR_002305
- DivK1c_001024
- SCHEMBL279450
- SPBio_000596
- XJLATMLVMSFZBN-VYDXJSESSA-N
- ERK5-5P14
- HMS503M09
- KBio1_001024
- KBio3_001599
- NINDS_001024
- DTXCID401357345
- HMS3260A21
- ZINC3979014
- Tox21_500010
- BBF-00543
- BDBM50089194
- CCG-38543
- CID443600
- EX-A11832
- HB3737
- MFCD00058569
- MFCD00080257
- AKOS015894413
- C19-H35-N3-O5
- CID:443600
- DB04310
- LP00010
- SDCCGSBI-0049999.P004
- IDI1_001024
- NCGC00093535-01
- NCGC00093535-02
- NCGC00093535-03
- NCGC00093535-04
- NCGC00093535-07
- NCGC00260695-01
- AJ-47578
- DA-60794
- LS-97940
- SID:310264845
- HY-113952
- CS-0064758
- EU-0100010
- FT-0629728
- NS00011711
- J1.369.062F
- A 6671
- C12056
- F82262
- (R)-N4-hydroxy-N1-((S)-1-((S)-2-(hydroxymethyl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)-2-pentylsuccinamide
- A806765
- C010531
- SR-01000075681
- I04-9250
- Q4676979
- SR-01000075681-1
- SR-01000075681-5
- Actinonin in combination with isoniazid and rifampicin
- BRD-K24621118-001-02-5
- BRD-K24621118-001-03-3
- (2R)-N'-hydroxy-N-[(2S)-1-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-2-pentylbutanediamide
- 2-carboxyethanethiolate-tributylstannanyl tributylstannanylium
- Octanohydroxamic acid, 3-((1-((2-(hydroxymethyl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamoyl)-
- (2R)-2-[2-(hydroxyamino)-2-oxo-ethyl]-N-[(1S)-1-[(2S)-2-(hydroxymethyl)pyrrolidine-1-carbonyl]-2-methyl-propyl]heptanamide
- 2-[(FORMYL-HYDROXY-AMINO)-METHYL]-HEPTANOIC ACID [1-(2-HYDROXYMETHYL-PYRROLIDINE-1-CARBONYL)-2-METHYL-PROPYL]-AMIDE
- 3-[[1-[(2-(Hydroxymethyl)-1-pyrrolidinyl)carbonyl]-2-methylpropyl]carbamoyl]octanohydroxamic acid
- BB2
- Butanediamide, N4-hydroxy-N1-(1-((2-(hydroxymethyl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)-2-pentyl-, stereoisomer
- (2R)-2-(2-(hydroxyamino)-2-oxo-ethyl)-N-((1S)-1-((2S)-2-(hydroxymethyl)pyrrolidine-1-carbonyl)-2-methyl-propyl)heptanamide
- (2R)-N'-hydroxy-N-((2S)-1-((2S)-2-(hydroxymethyl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)-2-pentylbutanediamide
- (2R)-N~4~-hydroxy-N~1~-[(1S)-1-{[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]carbonyl}-2-methylpropyl]-2-pentylbutanediamide
- (2R)-N~4~-Hydroxy-N~1~-{(2S)-1-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}-2-pentylbutanediamide
- (2R)-N4-HYDROXY-N1-((2S)-1-((2S)-2-(HYDROXYMETHYL)PYRROLIDIN-1-YL)-3-METHYL-1-OXOBUTAN-2-YL)-2-PENTYLBUTANEDIAMIDE
- (R)-3-[[[(S)-2-[(2S)-2-(Hydroxymethyl)pyrrolidine-1-yl]-2-oxo-1-isopropylethyl]amino]carbonyl]octanehydroxamic acid
- (R)-N -Hydroxy-N-[(S)-1-[[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-2-pentylbutanediamide
- (R)-N*4*-Hydroxy-N*1*-[(S)-1-((S)-2-hydroxymethyl-pyrrolidine-1-carbonyl)-2-methyl-propyl]-2-pentyl-succinamide
- 13434-99-6
- Butanediamide, N4-hydroxy-N1-[(1S)-1-[[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-2-pentyl-, (2R)-
- N'-hydroxy-N-(1-(2-(hydroxymethyl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)-2-pentylbutanediamide
- N*4*-Hydroxy-N*1*-[(S)-1-((S)-2-hydroxymethyl-pyrrolidine-1-carbonyl)-2-methyl-propyl]-2-(R)-pentyl-succinamide
- N*4*-Hydroxy-N*1*-[1-(2-hydroxymethyl-pyrrolidine-1-carbonyl)-2-methyl-propyl]-2-pentyl-succinamide
- Octanohydroxamic acid, 3-[[1-[[2-(hydroxymethyl)-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamoyl]-